COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,763 Articles (22,946 medRxiv, 8,817 bioRxiv)

Most recent first Previous |  Page 258: Articles 2571-2580  | Next

Continuous quality improvement with a two-step strategy effective for large-scale SARS-CoV-2 screening at the Tokyo 2020 Olympic and Paralympic Games
Miyachi, H., Asai, S., Kuroki, R., Omi, K., Ikenoue, C., Shimada, S.
10.1101/2024.05.29.24307666 — Posted: 2024-05-29
Differential prevalence and risk factors for infection with coronaviruses in bats collected during 2020 in Yunnan Province, China
Li, R., Tendu, A., Kane, Y., Omondi, V., Ying, J., Mao, L., Xu, S., Xu, R., Chen, X., Chen, Y., Declere, S. D., Bienes, K. M., Fassatoui, M., Hughes, A. C., Berthet, N., Wong, G.
10.1101/2024.05.28.596354 — Posted: 2024-05-29
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Wang, Q., Mellis, I. A., Bowen, A., Kowalski-Dobson, T., Valdez, R., Katsamba, P. S., Shapiro, L., Gordon, A., Guo, Y., Ho, D. D., Liu, L.
10.1101/2024.05.29.596362 — Posted: 2024-05-29
Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2
Long, J. M., Miao, V. N., Owings, A. H., Tang, Y., Bromley, J. D., Kazer, S. W., Kimler, K., Asare, C., Ziegler, C. G. K., Ibrahim, S., Jivanjee, T., George, M., Navia, A. W., Drake, R. S., Parker, A., Billingsley, B. C., Dotherow, P., Tarugu, S., Kota, S. K., Laird, H., Wichman, T. G., Davis, Y. T., Dhaliwal, N. S., Pride, Y., Guo, Y., Senitko, M., Harvey, J., Bates, J. T., Diamond, G., Garrett, M. R., Robinson, D. A., Frame, I. J., Lyons, J. J., Robinson, T. O., Shalek, A. K., Horwitz, B. H., Glover, S. C., Ordovas-Montanes, J.
10.1101/2024.05.29.596308 — Posted: 2024-05-29
Dissecting the ocular impact of SARS-CoV-2 variants: Analysis of eye globe and retina in animal models
da Silva, J. I. G., Kersten, V., Munhoz Dati, L. M., Lins, B. B., Tozetto-Mendoza, T. R. A. P., Rodrigues, D. d. R. F., Barbosa, R. J. V., Lima, S. H., Villas Boas, L. S., da Silva, A. d. S., Chaim, K. T., Mendes-Correa, M. C., Russo, M., Mirotti, L., Pinto, M. A., Martins, R. A. P.
10.1101/2024.05.29.596469 — Posted: 2024-05-29
The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease
Carolin, A., Frazer, D., Yan, K., Bishop, C. R., Tang, B., Nguyen, W., Helman, S. L., Horvat, J., Larcher, T., Rawle, D. J., Suhrbier, A.
10.1101/2024.05.29.596393 — Posted: 2024-05-29
mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity
Samaan, P., Korosec, C., Budylowski, P., Chau, S. L. L., Pasculescu, A., Qi, F., Delgado-Brand, M., Tursun, T. R., Mailhot, G., Dayam, R. M., Arnold, C. R., Langlois, M.-A., Patel, A., de Launay, K. Q., Boyd, J. M., Takaoka, A., Colwill, K., McGeer, A., Straus, S., Gingras, A.-C., Heffernen, J. M., Ostrowski, M.
10.1101/2024.05.28.596157 — Posted: 2024-05-29
A CROSS-SECTIONAL STUDY OF THE PSYCHOLOGICAL IMPACT OF COVID-19 ON MEDICAL STUDENTS DURING & AFTER RECOVERY FROM COVID-19
Misra, A., Rane, D., Bhat, A.
10.1101/2024.05.28.24308043 — Posted: 2024-05-28
IL-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV (PLWH)
Gupta, A., Righi, E., Konnova, A., Sciammarella, C., Spiteri, G., Van Averbeke, V., Berkell, M., Hotterbeekx, A., Sartor, A., Mirandola, M., Malhotra-Kumar, S., Azzini, A. M., Pezzani, D., Monaco, M. G. L., Vanham, G., Porru, S., Tacconelli, E., Kumar-Singh, S.
10.1101/2024.05.28.24308045 — Posted: 2024-05-28
Advancing Sewage Sample Surveillance with OmiCrisp: A CRISPR-Based Platform for Variant-Specific SARS-CoV-2 Detection
Arora, R., B S, K., Roy, B., Shridhar, V., Gupta, V., Chandru, V.
10.1101/2024.05.28.24307854 — Posted: 2024-05-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).